ArticleTranslational oncology2026
Learning cancer genetics from domestic cats.
Article in Translational oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The domestic cat (Felis catus) shares key biological features with humans, including susceptibility to tumor development. Genomic analysis of 493 feline tumors across 13 histologically defined types revealed striking similarities but also differences to human cancers. These feline tumors arose spontaneously in immunocompetent hosts and environmentally relevant settings, which is reminiscent of the human disease. Like in human cancers, mutations in the tumor suppressor TP53 were frequently detected. In contrast, tumor-promoting gain-of-function point mutations in the RAS gene were not found in feline tumors. Functional studies demonstrate translational potential, such as high sensitivity of FBXW7-mutated feline tumoroids to vinca alkaloids. Despite challenges, including variable life histories of affected cats and significant differences in the metabolism of cats and humans, feline oncology could provide important comparative insights into cancer biology and therapeutic vulnerabilities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.